The Food and Drug Administration today released a to help commercial developers submit emergency use authorization requests for COVID-19 diagnostic tests that can be performed in non-laboratory settings and available by prescription or over-the-counter.

鈥淲e hope that with the innovation we鈥檝e seen in test development, we could see tests that you could buy at a drug store, swab your nose or collect saliva, run the test, and receive results within minutes at home, once these tests become available,鈥 said FDA Commissioner Stephen Hahn, M.D. 鈥淭hese types of tests will be a game changer in our fight against COVID-19 and will be crucial as the nation looks toward reopening.鈥

In other news, FDA yesterday issued emergency use authorizations to  and for molecular diagnostic tests for SARS-CoV-2. The agency also health care providers and the public not to use hand sanitizers containing methanol. FDA has updated its of hand sanitizer products; in most cases, methanol does not appear on the product label.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
 The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥